Google Chrome
Safari
Firefox
Edge
Article / Oct 02, 2018
Efficiency Demands Drive Advances in API Labs
Pharmaceutical Technology, October 2, 2018
Search
Press Release / Nov 11, 2021
Hovione invests $170 million in new capacity and capabilities
Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives
Corticosteroids
Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.
Drug Substance Development
Hovione designs smarter, safer, and more efficient API processes—built on science, strengthened by data, enriched by experience, and ready for scale—helping you move faster, control complexity, and bring your product to market with confidence.
Press Release / Mar 07, 2024
Hovione partners with Dragonfly Technologies to offer micellar chemistry technology to customers as a sustainable alternative to conventional chemical processes
The agreement provides Hovione with the capability to develop chemistry-in-water, enabling a significant reduction in carbon footprint compared to conventional chemical processes relying on traditional organic solvents.
Hovione Capacity Expansion
Hovione is Growing
Hovione Lumiar
Office and R&D Center
Hydrogenations
Hovione has vast experience in developing hydrogenation processes using both heterogeneous and homogeneous catalysis.